Key result
Thrombolysis achieved a complete clinical and hemodynamic response in 90.5% of patients with prosthetic heart valve thrombosis, with a mortality rate of 6.6% in the thrombolysis group.
Why the study?
The study aimed to evaluate the clinical presentation, diagnostic features, treatment strategies, and complications of prosthetic heart valve thrombosis, and to determine the efficacy, outcomes, and complications of thrombolytic therapy during hospital stay.
Does thrombolysis improve outcomes and provide a safe first-line treatment for patients with prosthetic heart valve thrombosis?
Observational (n=110)
No
Does thrombolysis improve outcomes and provide a safe first-line treatment for patients with prosthetic heart valve thrombosis?
Thrombolysis is an effective and relatively safe first-line therapy for prosthetic heart valve thrombosis, achieving a 90.5% success rate, particularly in settings where immediate surgical options are limited.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for thrombolysis in prosthetic valve thrombosis; randomized trials needed before practice change.
Patil et al. (2019) conducted an observational in Prosthetic heart valve thrombosis (n=110). Thrombolysis (Streptokinase or Urokinase) vs. Surgery or conservative management was evaluated on Complete response to thrombolysis. Thrombolysis achieved a complete clinical and hemodynamic response in 90.5% of patients with prosthetic heart valve thrombosis, with a mortality rate of 6.6% in the thrombolysis group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: